Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2005
05/26/2005US20050113358 Enzyme inhibitors for erectile dysfunction and sexual disorders
05/26/2005US20050113349 2-Alpha vitamin D derivatives having substituents
05/26/2005US20050113322 Oligonucleotides which hybridize to inhibit expression; nucleosides; chimera; colloids; cardiovascular disorders; nervous system disorders; diabetes; ischemia/reperfusion injuries
05/26/2005US20050113312 2-0-(-d-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containning compositions comprising it
05/26/2005US20050113308 Pentapetide containing a proline amino acid; cytotoxic agent
05/26/2005US20050113301 Administering calcitonin and dehydroepiandrosterone (DHEA) to patient being treated for systemic lupus erythematosus where the immunosuppressant tends to reduce bone mineral density(BMD); osteoporosis
05/26/2005US20050113299 Protein a compositions and methods of use
05/26/2005US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/26/2005US20050112721 Chimeric peptide immunogens
05/26/2005US20050112565 Proteases
05/26/2005US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus
05/26/2005US20050112127 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
05/26/2005US20050112069 Pharmaceutical composition of a pde4 or pde 3/4 inhibitor and histamine receptor antagonist
05/26/2005US20050112060 Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination
05/26/2005CA2812856A1 Interleukin-10 antibodies
05/26/2005CA2544603A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
05/26/2005CA2543920A1 Il-18 binding proteins
05/25/2005EP1533313A1 Novel derivative of flavone c-glycoside and composition containing the same
05/25/2005EP1533294A1 Beta-alanine derivative and use thereof
05/25/2005EP1532986A2 Pharmaceutical composition for treatment of rhinitis
05/25/2005EP1532278A2 Diagnosis of chronic rejection
05/25/2005EP1532250A1 Fcyriia transgenic animal model for autoimmune disease
05/25/2005EP1532242A2 Methods for preparing purified prostaglandin e synthase
05/25/2005EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/25/2005EP1532176A2 Cd200-receptor mediated modulation of bone development
05/25/2005EP1532172A2 Immunogenic composition comprising an il-13 element and t cell epitopes, and itstherapeutic use
05/25/2005EP1532145A1 Pyrazole compositions useful as inhibitors of gsk-3
05/25/2005EP1532135A1 Nf-kb inhibitors
05/25/2005EP1532133A1 Nf-:b inhibitors
05/25/2005EP1532130A1 Process for the production of an immunosuppressant
05/25/2005EP1532124A1 Novel compounds
05/25/2005EP1532121A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives
05/25/2005EP1531847A2 Pharmaceutical formulation
05/25/2005EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
05/25/2005EP1531821A2 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors
05/25/2005EP1531818A1 Topical treatment of skin diseases
05/25/2005EP1531817A1 Glycinamide derivatives as raf-kinase inhibitors
05/25/2005EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
05/25/2005EP1531802A1 Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
05/25/2005EP1531795A1 Formulations limiting spread of pulmonary infections
05/25/2005EP1531793A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
05/25/2005EP1438390A4 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
05/25/2005EP1341791B1 Thioether substituted imidazoquinolines
05/25/2005EP1282592B1 Use of amines
05/25/2005EP1259231B1 Naphthoquinone derivatives as cd45 inhibitors
05/25/2005EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005EP1113813B1 In-vitro method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
05/25/2005EP1027061B1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants
05/25/2005EP0907652B1 Immunosuppressive compounds and methods
05/25/2005EP0907370B1 Hla-a2.1 binding peptides and their uses
05/25/2005EP0888541B1 Cryptic peptides and method for their identification
05/25/2005EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
05/25/2005EP0813419B1 Modulators of regulatory proteins
05/25/2005CN1620510A Cytokine protein family
05/25/2005CN1620500A Corona-virus-like particles comprising functionally deleted genomes
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620461A 2-amino-propanol derivatives
05/25/2005CN1620458A 噻吩并嘧啶 Thienopyrimidine
05/25/2005CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives
05/25/2005CN1620448A Piperidine-2, 6-diones heterocyclically substituted in the 3-position
05/25/2005CN1620442A Five-membered-ring compound
05/25/2005CN1620438A 5, 6-diaryl-pyrazine-2-amide derivatives as CBI antagonists
05/25/2005CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
05/25/2005CN1620431A (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620414A 维生素d类似物 Vitamin d analogues
05/25/2005CN1620311A Therapeutic agent
05/25/2005CN1620309A Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
05/25/2005CN1620307A Anti-HIV agent
05/25/2005CN1620303A Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient
05/25/2005CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies
05/25/2005CN1620299A Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
05/25/2005CN1620297A 止痒剂 Antipruritic
05/25/2005CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use
05/25/2005CN1620283A Dispersions for formulating slightly or poorly soluble active ingredients
05/25/2005CN1618969A Mammalian sytokine-like polypeptide-10
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1618465A 联合疫苗组合物 Combined vaccine composition
05/25/2005CN1618457A Method for preparing prepn. of immune modulation factor
05/25/2005CN1618435A Oral liquor for promoting-blood circulation and removing blood stasis contg. Radix astragali and ginseng
05/25/2005CN1618425A Composition contg. theaflavin and its derivatives, prepn. method and application thereof
05/25/2005CN1618334A Health-care food with function of increasing immunity, and its prepn. method
05/25/2005CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis
05/25/2005CN1203179C DNA sequence and recombination production method of graminae allergen
05/25/2005CN1203071C Polysaccharidic esters of N-derivatives of glutamic acid
05/25/2005CN1203069C Substituted piperidines, medicaments containing these compounds, and methods for production thereof
05/25/2005CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient
05/25/2005CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
05/25/2005CN1202863C Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
05/25/2005CN1202815C Delayed-action form of administration containing tramadol saccharinate
05/25/2005CA2448831A1 Multi-stage cascade boosting vaccine
05/24/2005US6897318 Process for making substituted pyrazoles
05/24/2005US6897290 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H
05/24/2005US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole
05/24/2005US6897226 NK-1 receptor active amine oxide prodrugs
05/24/2005US6897221 Urea substituted imidazoquinolines
05/24/2005US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
05/24/2005US6897210 Anticancer agents; antiarthritic agents
1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 1172